News

Amsino Medical Group Company announces transformational investment from Novo Tellus

Posted: June 26, 2024 | News, Press

Amsino Medical Group Company announces transformational investment from Novo Tellus

Amsino Medical Group, a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain.

2024 Amsino Holiday Closures

Posted: October 15, 2024 | News

2024 Amsino Holiday Closures

As we approach the holiday season, we want to inform you of Amsino’s upcoming holiday closures and year-end shipping schedule.

Amsino Acquires Enteral Feeding Pump Products from Alcor Scientific

Posted: July 24, 2024 |

Amsino Acquires Enteral Feeding Pump Products from Alcor Scientific

Amsino Medical Group Company (“Amsino”), a global provider of medical consumable devices, announced today that it has acquired Alcor Scientific’s enteral feeding pump products, including Sentinel and SentinelPlus.

Amsino Shanghai Welcomes Visitors from ICU Medical Japan

Posted: October 24, 2023 | News

Amsino Shanghai Welcomes Visitors from ICU Medical Japan

Amsino was honored to welcome visitors from ICU Medical Japan. Dr. Richard Lee, CEO and Chairman of Amsino Medical Group awarded them for the outstanding sales and marketing of RECEPTAL Twist in 2022. "We are very pleased to see RECEPTAL's continuous growth in the Japan market which was supported by the successful launch of Twist. We are grateful for your efforts and cooperation always" said Dr. Richard Lee in the meeting. 

Amsino Granted US Patent for RECEPTAL Twist

Posted: September 25, 2023 |

Amsino Granted US Patent for RECEPTAL Twist

Amsino Medical Co. Ltd. is proud to share that the United States Patent and Trademark Office (USPTO) has approved our application for a patent for RECEPTAL Twist. The Twist system was developed by Amsino President and CEO, Dr. Richard Lee, in partnership with Amsino Research Fellow, Zhongze Li.

Amsino to Exhibit at MEDICA 2023

Posted: August 21, 2023 | News

Amsino to Exhibit at MEDICA 2023

Pomona, CA – August 21, 2023 | Amsino International, Inc. is excited to be exhibiting at MEDICA later this year! MEDICA will take place in Düsseldorf, Germany from 13-16 November 2023.

Amsino Awarded ISO Certifications for Environmental and Employee Safety Compliance

Posted: August 14, 2023 | News

Amsino Awarded ISO Certifications for Environmental and Employee Safety Compliance

Pomona, CA – August 14, 2023 | Amsino International is proud to announce that our Kunshan manufacturing facility (Kunshan, China) has been awarded the ISO 14001 and ISO 45001 certificates for our outstanding commitment to quality management and occupational health and safety standards.

Amsino International to Exhibit at China International Medical Equipment Fair (CMEF)

Posted: May 11, 2023 | News, Press

Amsino International to Exhibit at China International Medical Equipment Fair (CMEF)

Amsino International is excited to be exhibiting at the China International Medical Equipment Fair (CMEF) May 14-19, 2023. The event will be held at the National Exhibition and Convention Center in Shanghai, China. Be sure to visit Amsino in the International Hall (Hall 6, Floor 2) at Booth #D24. Our team looks forward to the opportunity to meet and network with our fellow industry leaders throughout the event.

AMSINO ANNOUNCES GROUP PURCHASING AGREEMENT WITH CAPSTONE HEALTH ALLIANCE

Posted: April 19, 2023 |

AMSINO ANNOUNCES GROUP PURCHASING AGREEMENT WITH CAPSTONE HEALTH ALLIANCE

Today, Amsino announces that they have been awarded a group purchasing agreement with Capstone Health Alliance. Capstone is a regional group purchasing organization in partnership with Premier, representing well over 250 hospitals and 120 health systems across 24 States. It also represents over 30,000 non-acute healthcare members across continuum of care, and business and industry. Amsino has been appointed a Preferred Supplier for Pre-Filled Saline Flush Syringes. The agreement is in place until March 2026.

  • Follow Us: